{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:46:15Z","timestamp":1773211575599,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.endonu.2012.07.007","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T10:33:58Z","timestamp":1349001238000},"page":"561-569","source":"Crossref","is-referenced-by-count":9,"title":["P\u00e9ptido similar al glucag\u00f3n tipo 1 y supervivencia de la c\u00e9lula cardiaca"],"prefix":"10.1016","volume":"59","author":[{"given":"Susana","family":"Ravassa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Zudaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2012.07.007_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.physiol.010908.163111","article-title":"Cell death in the pathogenesis of heart disease: mechanisms and significance","volume":"72","author":"Whelan","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0010","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.2174\/138161208786071317","article-title":"Cardiac metabolism in myocardial ischemia","volume":"14","author":"Rosano","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.endonu.2012.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI112160","article-title":"Myocardial reperfusion: a double-edged sword?","volume":"76","author":"Braunwald","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.endonu.2012.07.007_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2010.10.056","article-title":"Lethal myocardial reperfusion injury: a necessary evil?","volume":"151","author":"Ibanez","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0025","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1172\/JCI117504","article-title":"Reperfusion injury induces apoptosis in rabbit cardiomyocytes","volume":"94","author":"Gottlieb","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.endonu.2012.07.007_bib0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","article-title":"New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway","volume":"61","author":"Hausenloy","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.endonu.2012.07.007_bib0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2012.07.007_bib0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10741-007-9026-1","article-title":"Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection","volume":"12","author":"Hausenloy","year":"2007","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.endonu.2012.07.007_bib0045","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jcem-24-10-1076","article-title":"Plasma insulin response to oral and intravenous glucose administration","volume":"24","author":"Elrick","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2012.07.007_bib0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1210\/jcem-25-10-1317","article-title":"Intestinal factors in the control of insulin secretion","volume":"25","author":"McIntyre","year":"1965","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2012.07.007_bib0055","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.endonu.2012.07.007_bib0060","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jc.80.3.952","article-title":"Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo","volume":"80","author":"Deacon","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2012.07.007_bib0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0014-2999(96)00795-9","article-title":"Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor","volume":"318","author":"Knudsen","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0070","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2010.11.002","article-title":"Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications","volume":"124","author":"Nauck","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.endonu.2012.07.007_bib0075","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/gut.2008.150870","article-title":"Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis","volume":"58","author":"Marzioni","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.endonu.2012.07.007_bib0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1476-5381.2009.00486.x","article-title":"Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection","volume":"159","author":"Harkavyi","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2010.05802.x","article-title":"Gastrointestinal hormones and the regulation of \u03b2-cell mass","volume":"1212","author":"Lavine","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.endonu.2012.07.007_bib0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/978-90-481-3271-3_23","article-title":"Clinical approaches to preserve beta-cell function in diabetes","volume":"654","author":"Wajchenberg","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0095","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00125-005-1787-2","article-title":"Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B","volume":"48","author":"Li","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.endonu.2012.07.007_bib0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.regpep.2011.01.003","article-title":"GLP-1-derived nonapeptide GLP-1(28-36) amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes","volume":"167","author":"Tomas","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.endonu.2012.07.007_bib0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endonu.2012.07.007_bib0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4093\/dmj.2011.35.5.437","article-title":"Understanding the cardiovascular effects of incretin","volume":"35","author":"Yoon","year":"2011","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.endonu.2012.07.007_bib0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1463-1326.2010.01345.x","article-title":"Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control","volume":"13","author":"Anagnostis","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.endonu.2012.07.007_bib0120","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.111.064139","article-title":"The incretin axis in cardiovascular disease","volume":"124","author":"Plutzky","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.endonu.2012.07.007_bib0125","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and \u2013independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.endonu.2012.07.007_bib0130","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/en.137.7.2968","article-title":"Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor","volume":"137","author":"Bullock","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.endonu.2012.07.007_bib0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(94)01430-9","article-title":"Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences","volume":"358","author":"Wei","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.endonu.2012.07.007_bib0140","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/en.2003-0007","article-title":"Cardiac function in mice lacking the glucagon-like peptide-1 receptor","volume":"144","author":"Gros","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.endonu.2012.07.007_bib0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.endonu.2012.07.007_bib0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.CIR.104.3.330","article-title":"Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo","volume":"104","author":"Matsui","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.endonu.2012.07.007_bib0155","doi-asserted-by":"crossref","first-page":"33B","DOI":"10.1016\/j.amjcard.2011.03.046","article-title":"Cardiovascular effects of glucagonlike peptide-1 agonists","volume":"108","author":"Davidson","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00210-010-0559-9","article-title":"GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats","volume":"382","author":"Ku","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0165","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"Sauv\u00e9","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.endonu.2012.07.007_bib0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00210-011-0665-3","article-title":"DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia\/reperfusion","volume":"384","author":"Ku","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-7120-9-43","article-title":"The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure","volume":"9","author":"Hlebowicz","year":"2011","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.endonu.2012.07.007_bib0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1464-5491.2010.03207.x","article-title":"Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men","volume":"28","author":"Nathanson","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.endonu.2012.07.007_bib0185","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","article-title":"Apoptosis in myocytes in end-stage heart failure","volume":"335","author":"Narula","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2012.07.007_bib0190","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI31060","article-title":"Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure","volume":"117","author":"Nakayama","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.endonu.2012.07.007_bib0195","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.RES.85.9.856","article-title":"Myocyte death in the failing human heart is gender dependent","volume":"85","author":"Guerra","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.endonu.2012.07.007_bib0200","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/en.2009-1197","article-title":"Glucagon-like peptide (GLP)-1(9-36) amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor","volume":"151","author":"Ban","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.endonu.2012.07.007_bib0205","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/00029330-200811010-00005","article-title":"Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation","volume":"121","author":"Xie","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.endonu.2012.07.007_bib0210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.endonu.2012.07.007_bib0215","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.00885.2010","article-title":"Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes","volume":"300","author":"Ravassa","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jss.2009.03.016","article-title":"Single dose GLP-1-Tf ameliorates myocardial ischemia\/reperfusion injury","volume":"165","author":"Matsubara","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.endonu.2012.07.007_bib0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2008.10.033","article-title":"Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury","volume":"53","author":"Timmers","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0230","doi-asserted-by":"crossref","first-page":"e23570","DOI":"10.1371\/journal.pone.0023570","article-title":"Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia\/reperfusion injury: evidence for improving cardiac metabolic efficiency","volume":"6","author":"Bao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.endonu.2012.07.007_bib0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10557-010-6242-z","article-title":"Neonatal exendin-4 leads to protection from reperfusion injury and reduced rates of oxidative phosphorylation in the adult rat heart","volume":"24","author":"Brown","year":"2010","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.endonu.2012.07.007_bib0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.regpep.2007.10.001","article-title":"Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart","volume":"146","author":"Sonne","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.endonu.2012.07.007_bib0245","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/FJC.0b013e3181dcd240","article-title":"Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits","volume":"55","author":"Iwasa","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1476-5381.2011.01357.x","article-title":"Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits","volume":"164","author":"Iwasa","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/jpet.104.073890","article-title":"Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines","volume":"312","author":"Nikolaidis","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.endonu.2012.07.007_bib0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10557-007-6030-6","article-title":"Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway","volume":"21","author":"Bose","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.endonu.2012.07.007_bib0265","doi-asserted-by":"crossref","first-page":"H1454","DOI":"10.1152\/ajpheart.00867.2009","article-title":"The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA","volume":"298","author":"Ye","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0270","first-page":"77","article-title":"Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia","volume":"19","author":"Huisamen","year":"2008","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.endonu.2012.07.007_bib0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10557-010-6271-7","article-title":"Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats","volume":"25","author":"Huisamen","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.endonu.2012.07.007_bib0280","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0031-1271777","article-title":"Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents","volume":"43","author":"Dokken","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.endonu.2012.07.007_bib0285","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.resuscitation.2010.01.031","article-title":"Glucagon-like peptide-1 (GLP-1) attenuates post-resuscitation myocardial microcirculatory dysfunction","volume":"81","author":"Dokken","year":"2010","journal-title":"Resuscitation"},{"key":"10.1016\/j.endonu.2012.07.007_bib0290","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","article-title":"Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts","volume":"317","author":"Zhao","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.endonu.2012.07.007_bib0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2261-9-31","article-title":"Lack of cardioprotection from subcutaneously and preischemic administered liraglutide in a closed chest porcine ischemia reperfusion model","volume":"9","author":"Kristensen","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.endonu.2012.07.007_bib0300","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0196-9781(03)00108-6","article-title":"Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium","volume":"24","author":"Kavianipour","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.endonu.2012.07.007_bib0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01907957","article-title":"Coronary collateral circulation in the pig: correlation of collateral flow with coronary bed size","volume":"76","author":"White","year":"1981","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-10-85","article-title":"Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure","volume":"10","author":"Yin","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/eurheartj\/ehr302","article-title":"Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes","volume":"33","author":"Zaruba","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.endonu.2012.07.007_bib0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCHEARTFAILURE.108.766402","article-title":"Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat","volume":"1","author":"Poornima","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.endonu.2012.07.007_bib0325","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1475-2840-9-76","article-title":"Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure","volume":"9","author":"Liu","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0330","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.endonu.2012.07.007_bib0335","doi-asserted-by":"crossref","first-page":"H2401","DOI":"10.1152\/ajpheart.00347.2005","article-title":"Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy","volume":"289","author":"Nikolaidis","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0340","doi-asserted-by":"crossref","first-page":"e17178","DOI":"10.1371\/journal.pone.0017178","article-title":"Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy","volume":"6","author":"Vyas","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.endonu.2012.07.007_bib0345","doi-asserted-by":"crossref","first-page":"G225","DOI":"10.1152\/ajpgi.00274.2011","article-title":"Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL\/6J mice fed a Western diet","volume":"302","author":"Mells","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.endonu.2012.07.007_bib0350","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-200306000-00012","article-title":"Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats","volume":"21","author":"Yu","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.endonu.2012.07.007_bib0355","doi-asserted-by":"crossref","first-page":"e27861","DOI":"10.1371\/journal.pone.0027861","article-title":"Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy","volume":"6","author":"Chaykovska","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.endonu.2012.07.007_bib0420","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clinthera.2011.04.006","article-title":"Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes","volume":"33","author":"Ovalle","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.endonu.2012.07.007_bib0425","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF03346698","article-title":"Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies","volume":"34","author":"Giorgino","year":"2011","journal-title":"J Endocrinol Invest"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092212002380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092212002380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T21:59:08Z","timestamp":1714427948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092212002380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1575092212002380"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2012.07.007","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}